125545 [ 95% WORKING ]

: Supported for both adult and pediatric patients.

Below are draft social media posts tailored for different professional audiences based on this application:

: A popular Explorer Forum thread (ID 125545) regarding manual transfer case conversions. 125545

#Biosimilars #FDA #Hematology #PharmaNews #HealthcareInnovation Clinical Spotlight: Retacrit (epoetin alfa-epbx)

📢

: A community discussion on Pilots of America regarding the FAA Handbook and cloud base calculations. 125545Orig1s000 - accessdata.fda.gov

The number most commonly refers to BLA 125545 , an FDA Biologics License Application for Retacrit (epoetin alfa-epbx) , which is a biosimilar to Epogen and Procrit used to treat anemia. : Supported for both adult and pediatric patients

#Nursing #Oncology #Nephrology #ClinicalGuidelines #DrugSafety